A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.
Rachel DeVinney, MPH, CHES
Advertisement
Articles by Rachel DeVinney, MPH, CHES
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
2
Drug Price Drives Value of MASH Therapies More Than Efficacy
3
IRA, 340B, Medicaid: The Policy Pressures on Community Oncology
4
Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures
5